Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)

  1. Schneeweiss, A.
  2. Chia, S.
  3. Hickish, T.
  4. Harvey, V.
  5. Eniu, A.
  6. Hegg, R.
  7. Tausch, C.
  8. Seo, J.H.
  9. Tsai, Y.-F.
  10. Ratnayake, J.
  11. McNally, V.
  12. Ross, G.
  13. Cortés, J.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Argitalpen urtea: 2013

Alea: 24

Zenbakia: 9

Orrialdeak: 2278-2284

Mota: Artikulua

DOI: 10.1093/ANNONC/MDT182 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus